Azenta, Inc. (NASDAQ:AZTA – Get Free Report) saw a significant growth in short interest in the month of September. As of September 15th, there was short interest totalling 5,380,000 shares, a growth of 5.3% from the August 31st total of 5,110,000 shares. Currently, 11.3% of the shares of the stock are sold short. Based on an average trading volume of 590,300 shares, the days-to-cover ratio is presently 9.1 days.
Azenta Trading Down 1.9 %
Shares of NASDAQ AZTA opened at $47.50 on Wednesday. The business has a 50-day moving average of $51.37 and a 200-day moving average of $53.11. The firm has a market capitalization of $2.56 billion, a price-to-earnings ratio of -17.53 and a beta of 1.47. Azenta has a 12 month low of $44.00 and a 12 month high of $69.16.
Azenta (NASDAQ:AZTA – Get Free Report) last released its quarterly earnings results on Tuesday, August 6th. The company reported $0.16 EPS for the quarter, topping analysts’ consensus estimates of $0.07 by $0.09. The business had revenue of $173.00 million during the quarter, compared to analysts’ expectations of $166.14 million. Azenta had a negative net margin of 23.66% and a positive return on equity of 0.89%. The business’s quarterly revenue was up 4.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.13 EPS. On average, analysts predict that Azenta will post 0.33 earnings per share for the current year.
Institutional Inflows and Outflows
Wall Street Analysts Forecast Growth
A number of research firms recently weighed in on AZTA. Evercore ISI decreased their target price on shares of Azenta from $53.00 to $50.00 and set an “in-line” rating on the stock in a report on Tuesday. Needham & Company LLC restated a “buy” rating and set a $69.00 price target on shares of Azenta in a research report on Wednesday, August 7th. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $66.40.
Get Our Latest Research Report on AZTA
About Azenta
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
Further Reading
- Five stocks we like better than Azenta
- 5 discounted opportunities for dividend growth investors
- Why Lennar Stock Could Be the Best Play in the Housing Market
- The How And Why of Investing in Oil Stocks
- 2 Energy Stocks Fueling the AI Datacenter Boom
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.